Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-0466-2022 — Proteus 235; Version: PTS-8 versions before PTS-8.7.2

U.S. FDA — Device Enforcement · Belgium · 2021-11-29 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-0466-2022
Date of alert
2021-11-29
Country / jurisdiction
Belgium
Risk level
Class II
Risk type
recall
Brand
Ion Beam Applications S.A.
Product category
device
Product type
Devices
Reported risk: Proton Therapy System (PTS) software can be started in the clinical environment (clinical user) while some processes are still running in the test environment (tcs user). Initiating the startup of the clinical processes in the environment is not prevented even if some processes of the test environment (tcs) are still running. It may lead to situations where the system is using test processes without notifying the clinical user. If the versions of the processes are different between both environments, this could have an impact on patient treatments.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.